Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
In a Japanese kindred with stapes ankylosis, broad thumbs and toes, and conductive hearing impairment (HP:0000381, HP:0000405), a heterozygous NOG c.682T>G (p.Cys228Gly) variant segregated with the brachydactyly type B2 phenotype in three affected individuals (PMID:26211601). The disorder follows an autosomal dominant inheritance with complete co-segregation in the family (2 additional affected relatives).
Functional studies of human NOG missense mutations demonstrate reduced secretion of functional noggin dimers (PMID:11562478) and impaired dimerization (PMID:25888563), consistent with a hypomorphic mechanism leading to haploinsufficiency. No studies have disputed the association of NOG with brachydactyly type B2. These data support the clinical utility of NOG sequencing in patients presenting with brachydactyly type B2 and related skeletal anomalies.
Key Take-home: Heterozygous hypomorphic NOG variants underlie autosomal dominant brachydactyly type B2 and should be included in diagnostic genetic testing.
Gene–Disease AssociationLimitedSingle kindred with NOG c.682T>G (p.Cys228Gly) segregating with brachydactyly type B2 in three affected individuals (PMID:26211601). Genetic EvidenceLimitedHeterozygous c.682T>G variant segregated in a single family with two additional affected relatives and no unrelated cases (PMID:26211601). Functional EvidenceModerateIn vitro studies show NOG missense mutations reduce noggin secretion and dimerization consistent with a hypomorphic mechanism (PMID:11562478; PMID:25888563). |